Press Events

The following press events will take place in the AAAAI press conference room. This is located in the Georgia World Congress Center, Building B, Level Two, Room B202. The speaker lineup is subject to change.

Saturday, March 4

Topics in Atopic Disease @ 11:15 am - 12:00 pm ET

“Evaluation of Risk Factors for Infections and Systemic Reactions (SRs) Associated with Subcutaneous and Sublingual Allergen Immunotherapy (SCIT and SLIT): AAAAI/ACAAI National Surveillance Study 2008-2015” (Abstract L8, Page AB377)

Tolly Epstein, MD, MS, FAAAAI, University of Cincinnati Division of Immunology, Allergy & Rheumatology, Ohio

“Maternal Vitamin E Plasma Isoform Concentrations and Association with Child Wheezing and Asthma Outcomes” (Abstract 263, Page AB83)

Cosby A. Stone, MD, Vanderbilt University Medical Center, Tennessee

“Mixed Infant Feeding - Direct Breastfeeding, Pumping and Feeding, and Formula Food Poses a Risk for Food Allergy in Early Childhood” (Abstract L32, Page AB385)

Ms. Joacy Mathias, University of Memphis, Tennessee

“The Role of Gender in the Association Between Obesity and Atopic Disease in Urban Children” (Abstract L38, Page AB387)

Sairaman Nagarajan, MD, MPH, SUNY Downstate Medical Center, New York

“Where Do Children with Asthma Die? A National Perspective from 2003 to 2014” (Abstract 283, Page AB89)

Anna J. Chen Arroyo, MD, MPH, Brigham and Women's Hospital, Massachusetts

Sunday, March 5

Research in Food Allergy Immunotherapy @ 11:15 am - 12:00 pm ET

“Long-term Walnut Oral Immunotherapy Induces Clinically Relevant Treatment Responses in Tree Nut Allergic Children” (Abstract 558, Page AB175)

Robbie Pesek, MD, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Arkansas

“Randomized Placebo-Controlled Multicenter Clinical Trial of Wheat Oral Immunotherapy” (Abstract L10, Page AB378)

Hugh A. Sampson, MD, FAAAAI, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York

“Sustained Unresponsiveness After Sublingual Immunotherapy for Peanut-allergic Children” (Abstract 559, Page AB175)

Edwin Kim, MD, University of North Carolina at Chapel Hill, North Carolina

“Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial” (Abstract L7, Page AB377)

Hugh A. Sampson, MD, FAAAAI, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York